Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

Chris Gibson, Recursion’s head, cited the role small business grants played in helping his company grow its business.

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

The new center at Bridge Labs will train the workforce powering North Texas’ biotech boom—helping startups speed therapies, ...

Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...